We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
-25.76%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
–
AUM
$74.4M
AUM Growth
-$37M
Cap. Flow
-$4.18M
Cap. Flow %
-5.61%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$3.06M
2
QTTB icon
Q32 Bio
QTTB
+$1.12M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
1
Dyne Therapeutics
DYN
$4.24B
$25.7M 34.58%
2,220,034
– –
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$13.5M 18.1%
2,207,772
– –
CNTA
3
DELISTED
Centessa Pharmaceuticals
CNTA
$12.2M 16.38%
3,931,818
– –
ALLO icon
4
Allogene Therapeutics
ALLO
$604M
$11.3M 15.2%
1,798,163
– –
KRON
5
DELISTED
Kronos Bio
KRON
$4.48M 6.02%
2,765,314
– –
LIAN
6
DELISTED
LianBio American Depositary Shares
LIAN
$3.74M 5.03%
2,282,084
– –
PRAX icon
7
Praxis Precision Medicines
PRAX
$8.8B
$3.5M 4.7%
97,978
-97,977
-50% -$3.06M
QTTB icon
8
Q32 Bio
QTTB
$452M
– –
-38,683
Closed -$1.12M

Similar funds

NC
Nucleo Capital Sao Paulo, Sp, Brazil $29.1M AUM 59.16% 1-Year Est. Return
PIM
Pinnacle Investment Management Hong Kong $28.9M AUM 32% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
RE
ROB Exploration New York $27.3M AUM 13.99% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
BCA
Burren Capital Advisors Gibraltar $33M AUM 47.67% 1-Year Est. Return
VCM
Vector Capital Management San Francisco, California $24.4M AUM 14.95% 1-Year Est. Return

Vida Ventures Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Vida Ventures Advisors held 8 positions worth $74.4M, down 33% from $111M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vida Ventures Advisors withdrew a net $4.18M in Q4 2022, closing 1 position and reducing 1 holding. Its most notable exit was Q32 Bio, an estimated $1.12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's biggest Q4 2022 reduction was Praxis Precision Medicines, cutting an estimated $3.06M.
  • Vida Ventures Advisors fully exited Q32 Bio in Q4 2022, selling an estimated $1.12M.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $74.4M portfolio in Q4 2022.
  • Vida Ventures Advisors opened 0 new positions and closed 1 in Q4 2022.
  • Vida Ventures Advisors's portfolio value fell 33% quarter-over-quarter to $74.4M.

Based on Vida Ventures Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.